Back to Search
YUSSEF BENNANI, M.D.
M.D.
Infectious Disease Physician
NPI: 1730478363IndividualAccepts Medicare
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MD.206918(LA)
CMS Specialties
PrimaryINFECTIOUS DISEASE
Education
TULANE UNIVERSITY SCHOOL OF MEDICINE
Class of 2011
Research & Publications (20)
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships.
PMID 19588934·J Med Chem·2009
7-preclinical
The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.
PMID 18683917·J Med Chem·2008
7-preclinical
4-[6-(2-Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration.
PMID 17169555·Bioorg Med Chem Lett·2007
7-preclinical
A new family of histamine H3 receptor antagonists based on a natural product: discovery, SAR, and properties of the series.
PMID 17806176·Inflamm Res·2007
7-preclinical
Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121.
PMID 16730751·Life Sci·2006
7-preclinical
Aza-retinoids as novel retinoid X receptor-specific agonists.
PMID 16364638·Bioorg Med Chem Lett·2006
8-other
The design and synthesis of a tricyclic single-nitrogen scaffold that serves as a 5-HT2C receptor agonist.
PMID 16750364·Bioorg Med Chem Lett·2006
7-preclinical
Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor.
PMID 16316670·Neuropharmacology·2006
7-preclinical
The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists.
PMID 16546379·Bioorg Med Chem Lett·2006
7-preclinical
Estimates of HIV incidence among persons testing for HIV using the sensitive/less sensitive enzyme immunoassy, New York City, 2001.
PMID 15851920·J Acquir Immune Defic Syndr·2005
8-other
Structure-activity relationships of arylbenzofuran H3 receptor antagonists.
PMID 15863316·Bioorg Med Chem Lett·2005
8-other
Achievement of behavioral efficacy and improved potency in new heterocyclic analogs of benzofuran H3 antagonists.
PMID 15928820·Inflamm Res·2005
7-preclinical
The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors.
PMID 15603939·Bioorg Med Chem Lett·2005
8-other
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.
PMID 15608078·J Pharmacol Exp Ther·2005
7-preclinical
4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention.
PMID 15634000·J Med Chem·2005
7-preclinical
Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists.
PMID 15745833·Bioorg Med Chem Lett·2005
8-other
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
PMID 15608077·J Pharmacol Exp Ther·2005
7-preclinical
Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity.
PMID 16146429·Epilepsia·2005
4-observational
Identification of novel and improved antimitotic agents derived from noscapine.
PMID 16279766·J Med Chem·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1542 TULANE AVE, RM. 331
NEW ORLEANS, LA 70112 - Phone
- (504) 568-5031
Quick Facts
- NPI
- 1730478363
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile